Skip to Content




ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antineoplastic agent

Chemical Name

(±)-Dietyl [1-[3-(2-chloroetyl)-3-nitrosoureido]etyl]phosphonate

Foreign Names

  • Fotemustinum (Latin)
  • Fotemustin (German)
  • Fotémustine (French)
  • Fotemustina (Spanish)

Generic Names

  • Fotemustine (OS: BAN)
  • Fotémustine (OS: DCF)
  • S 10036 (Servier) (IS)

Brand Names

  • Fotemustine-New Pioneer
    Asia Pioneer, China
  • Muphoran
    Italfarmaco, Italy; Laboratoires Thissen, Israel; Les Laboratoires Servier, China; Les Laboratoires Servier, France; Servier, Australia; Servier, Brazil; Servier, Portugal; Servier, Turkey; Servier Benelux, Belgium; Servier Laboratoires Industrie, Greece
  • Muphoran 200mg
    Servier, Luxembourg
  • Muphoran 200mg/4ml
    Servier Austria, Austria
  • Mustoforan
    Servier, Spain
  • Mustophoran
    Laboratorii Servier, Russian Federation; Les Laboratoires Servier, Romania; Servier, Czech Republic; Servier, Latvia; Servier, Poland; Servier, Slovakia; Thissen, Bulgaria
  • Mustophoran 200 mg/4 ml
    Servier, Hungary


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.